Allogeneic blood stem cell transplantation following non-myeloablative conditioning for the treatment of malignant and non-malignant diseases.

被引：0
|
作者：
Slavin, S [1 ]
Nagler, A [1 ]
Naparstek, E [1 ]
Ackerstein, A [1 ]
Kapelushnik, Y [1 ]
Varadi, G [1 ]
Allayan, H [1 ]
Kirschbaum, M [1 ]
Ben-Yosef, R [1 ]
Samuel, S [1 ]
机构：
[1] Hadassah Univ Hosp, Dept Bone Marrow Transplant, IL-91120 Jerusalem, Israel
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
225
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [41] Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases
    Abdulbaqi Al-toma
    Petula Nijeboer
    Gerd Bouma
    Otto Visser
    Chris JJ Mulder
    World Journal of Gastroenterology, 2014, (46) : 17368 - 17375
  • [42] Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease
    William J. Hogan
    Rainer Storb
    Immunologic Research, 2003, 28 : 1 - 11
  • [43] Incidence and outcome of thrombotic microangiopathy after allogeneic peripheral blood stem cell transplantation with non-myeloablative conditioning compared with myeloablative conditioning
    Willems, E
    Baron, F
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 : S46 - S46
  • [44] Preliminary results of an non-myeloablative conditioning regimen for allogeneic stem cell transplantation.
    Mackinnon, S
    Kottaridis, P
    Perry, A
    Chakrabarti, S
    Milligan, DW
    Pettengell, R
    Chopra, R
    Morgan, G
    Hale, G
    Waldmann, H
    Linch, DC
    Devereux, S
    Goldstone, AH
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 31 - 31
  • [45] Bronchiolitis obliterans in haematopoetic stem cell transplantation following non-myeloablative conditioning
    Scheidl, S.
    Kovacs, G.
    Zinke-Cerwenka, W.
    Reitter, S.
    Kovacs, G.
    Troester, N.
    Olschewski, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (17-18) : A53 - A54
  • [46] Risk for cytomegalovirus infection following non-myeloablative allogeneic stem cell transplantation
    Nachbaur, D
    Gunsilius, E
    Haun, M
    Larcher, C
    Gastl, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S96 - S97
  • [47] Therapeutic applications of non-myeloablative hematopoietic stem cell transplantation in malignant disease
    Hogan, WJ
    Storb, R
    IMMUNOLOGIC RESEARCH, 2003, 28 (01) : 1 - 11
  • [48] Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases
    Katsutsugu Umeda
    International Journal of Hematology, 2022, 116 : 41 - 47
  • [49] Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases
    Umeda, Katsutsugu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (01) : 41 - 47
  • [50] Non-myeloablative stem cell transplantation for autoimmune diseases
    Burt, RK
    Verda, L
    Oyama, Y
    Statkute, L
    Slavin, S
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2004, 26 (1-2): : 57 - 69
12345